Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2010 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Shares Outstanding (Entity) came in at $15.0 million in Q2 2026, little changed year-over-year from $15.0 million in Q2 2025, and little changed quarter-over-quarter from $15.0 million in Q1 2026.
Analysis
Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $15.0 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) changed 0.15% year-over-year to $15.0 million; the TTM figure through Jun 2026 stood at $15.0 million (changed 0.15% YoY), while the FY2025 annual figure was $15.0 million, up 7.2% from the prior year.
- Shares Outstanding (Entity) came in at $15.0 million for Q2 2026 at Cumberland Pharmaceuticals, roughly flat from $15.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $15.0 million in Q1 2026 to a low of $14.0 million in Q4 2024.
- Average Shares Outstanding (Entity) over 5 years is $14.5 million, with a median of $14.4 million recorded in 2022.
- Year-over-year, Shares Outstanding (Entity) retreated 2.79% in 2022 and rose 7.2% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $14.4 million in 2022, then dropped by 1.7% to $14.1 million in 2023, then dropped by 1.2% to $14.0 million in 2024, then gained by 7.2% to $15.0 million in 2025, then grew by 0.18% to $15.0 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $15.0 million in Q2 2026, $15.0 million in Q1 2026, and $15.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | 200.38 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 42.60 Mn |
| 10 | Cumberland Pharmaceuticals | 94.76 Mn | 90.90 Mn | - | 14.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.98 Mn |
| Mar 31, 2026 | 14.96 Mn |
| Dec 31, 2025 | 14.85 Mn |
| Sep 30, 2025 | 14.96 Mn |
| Jun 30, 2025 | 14.96 Mn |
| Mar 31, 2025 | 14.94 Mn |
| Dec 31, 2024 | 14.06 Mn |
| Sep 30, 2024 | 14.05 Mn |
| Jun 30, 2024 | 14.12 Mn |
| Mar 31, 2024 | 14.10 Mn |
| Dec 31, 2023 | 14.30 Mn |
| Sep 30, 2023 | 14.28 Mn |
| Jun 30, 2023 | 14.39 Mn |
| Mar 31, 2023 | 14.36 Mn |
| Dec 31, 2022 | 14.56 Mn |
| Sep 30, 2022 | 14.48 Mn |
| Jun 30, 2022 | 14.69 Mn |
| Mar 31, 2022 | 14.69 Mn |
| Dec 31, 2021 | 14.90 Mn |
| Sep 30, 2021 | 14.88 Mn |